|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 169.96 USD | -0.35% |
|
-1.41% | +0.71% |
Investment objective
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Price |
Change |
Varia. Jan 1. |
Weight | ||
|---|---|---|---|---|---|
| 441.36USD | +0.56% | -2.65% | 7.59% | ||
| 124.91USD | +3.01% | +1.77% | 7.41% | ||
| 330.41USD | +0.12% | +0.95% | 7.18% | ||
| 733.04USD | -1.20% | -5.03% | 6.13% | ||
| 359.27USD | +0.00% | -9.65% | 5.18% | ||
| 161.42USD | +1.35% | -7.25% | 3.69% | ||
| 237.68USD | -1.49% | +5.44% | 3.35% | ||
| 1,460.63USD | -2.40% | +4.77% | 2.59% | ||
| 231.25USD | -3.78% | +0.94% | 2.35% | ||
| 164.42USD | -2.46% | -6.57% | 2.01% | ||
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 169.96 $ | -0.35% | 1,924,953 |
| 15/01/26 | 170.56 $ | -1.31% | 1,519,803 |
| 14/01/26 | 172.83 $ | +0.88% | 1,820,512 |
| 13/01/26 | 171.32 $ | -0.05% | 1,207,246 |
| 12/01/26 | 171.40 $ | -0.57% | 1,755,689 |
Other stock markets
Delayed Quote Nasdaq
Last update January 16, 2026 at 09:00 pm
More quotesDescription
| US4642875565 | |
|---|---|
| Total Expense Ratio | 0.44% |
| Asset Class | Equities |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | ICE Biotechnology Index (TR) - USD |
| Autres ETFs | |
Features and characteristics
| Dividend Policy | Distribution |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Fund Structure | |
| Replication Model | |
| Date of creation |
04/02/2001
|
| Geographical Focus |
AuM evolution - 30/10/2025
| AuM (USD) | 6.58B |
|---|---|
| AuM 1M | 5.87B |
| AuM 3 months | 5.43B |
| AuM 6 months | 5.58B |
| AuM 12 months | 7.63B |
- Stock Market
- ETF
- IBB ETF
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















